Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.

[1]  A. Tofani,et al.  Somatostatin receptor imaging in small cell lung cancer using 111In‐DTPA-octreotide: a preliminary study , 1993, Nuclear medicine communications.

[2]  W. Nelp,et al.  Imaging lung cancer with radiolabeled antibodies. , 1993, Seminars in nuclear medicine.

[3]  J. Weinstock.  Neuropeptides and the regulation of granulomatous inflammation. , 1992, Clinical immunology and immunopathology.

[4]  A. Biggi,et al.  Detection of suspected primary lung cancer by scintigraphy with indium-111-anti-carcinoembryonic antigen monoclonal antibodies (type F023C5) , 1991, Journal of Nuclear Medicine.

[5]  E. Krenning,et al.  Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  T. Visser,et al.  In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Weinstock,et al.  Macrophages within the granulomas of murine Schistosoma mansoni are a source of a somatostatin 1-14-like molecule. , 1990, Cellular immunology.

[8]  J. Reubi,et al.  Somatostatin receptors are present in small‐cell but not in non‐small‐cell primary lung carcinomas: Relationship to EGF‐receptors , 1990, International journal of cancer.

[9]  G. T. Krishnamurthy,et al.  Evaluation of primary lung cancer with indium 111 anti‐carcinoembryonic antigen (type ZCE‐025) monoclonal antibody scintigraphy , 1990, Cancer.

[10]  R. Leonard.  Small cell lung cancer. , 1989, British Journal of Cancer.

[11]  R. Holle,et al.  Prognostic value of pretreatment carcinoembryonic antigen, neuron‐specific enolase, and creatine kinase‐BB levels in sera of patients with small cell lung cancer , 1988, Cancer.

[12]  A. Bogdén,et al.  In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue. , 1988, Biochemical and biophysical research communications.

[13]  S. Lamberts,et al.  Potential role of somatostatin analogues in the treatment of cancer , 1987, European journal of clinical investigation.

[14]  P. Andersen,et al.  Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Reichlin.  Somatostatin. , 1983, The New England journal of medicine.

[16]  R. Mascardo,et al.  Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor. , 1982, Endocrinology.

[17]  R. Livingston,et al.  Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study. , 1978, Annals of internal medicine.

[18]  M. Blaufox,et al.  Iodine-131 MIBG scintigraphy in small cell lung cancer , 2004, European Journal of Nuclear Medicine.

[19]  H. Sinzinger,et al.  131I-Metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection? , 2004, European Journal of Nuclear Medicine.

[20]  E. Krenning,et al.  Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors. , 1993, Acta oncologica.

[21]  G. Bonadonna,et al.  Handbook Of Medical Oncology , 1988 .

[22]  S. Reichlin.  Somatostatin (First of two parts) , 1983 .

[23]  J. Mcvie.  Cancer of the Lung and Pleura , 1982 .

[24]  Josef Korinek,et al.  Proceedings of the American Society of Clinical Oncology , 1982 .